July 21, 2025

Coping Trumps Pleasure in Predicting Comfort Eating

Researchers explore how psychological expectations—such as boredom relief and mood regulation—drive the frequency of comfort food consumption in adults.

Conexiant

July 15, 2025

Cementless Knee Implants Show Superior Outcomes in Patients With Obesity

A new review comparing knee implant methods in obese patients finds cementless fixation may improve implant survival and reduce loosening compared with cemented approaches, especially in patients with BMI ≥35 kg/m².

Conexiant

July 09, 2025

Four Diagnostic Paths Found to Predict Alzheimer’s

A study of over 24,000 patients identified four common diagnostic paths that lead to Alzheimer’s disease, with multi-step sequences posing higher risk than single conditions and showing reproducibility in a national validation cohort.

Conexiant

July 08, 2025

Mediterranean Diet’s 30-Year Legacy

A sweeping 30-year review confirms the Mediterranean-style diet lowers risks of heart disease, diabetes, cancer, and cognitive decline—while supporting global sustainability.

Conexiant

July 08, 2025

No Safe Level for Processed Foods

A meta-analysis finds no safe level of processed meat, sugary drinks, or industrial trans fats—each linked to increased chronic disease risk.

Conexiant

July 08, 2025

New Obesity Framework Reclassifies 1 in 5 Adults

EASO’s expanded obesity definition incorporating waist-to-height ratio and comorbidities reclassifies 18.8% of overweight adults, but mortality benefits remain uncertain.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

CGM Boosts Wound Healing, Lowers A1c: Study

Short-term CGM use improved A1c, wound healing, and reduced ED visits in diabetic foot patients, per data from ADA’s 85th Scientific Sessions.

Conexiant

June 27, 2025

Ecnoglutide Shows Strong Weight Loss in Trial

A once-weekly GLP-1 receptor agonist, ecnoglutide, led to significant and sustained weight loss in a large study of adults with overweight or obesity, with favorable safety outcomes reported at the ADA’s 85th Scientific Sessions.

Conexiant